Luis Varela-Rodríguez

7PUBLICATIONS
29CO-AUTHORS
Medical infection agents (incl. prions)Foetal development and medicineCharacterisation of biological macromoleculesPlant pathologyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 28, 2026
Acanthamoeba castellanii: Non-Steroidal Anti-Inflammatory Drugs Affect Adhesion, Motility, and Encystment, Suggesting a Link with a gp63-like Protein Candidate.

Verónica I Hernández-Ramírez, Hugo Varela-Rodríguez, Luis Varela-Rodríguez

|Feb 25, 2025
Folliculogenesis: A Cellular Crosstalk Mechanism.

Bianca Viviana Orozco-Galindo, Blanca Sánchez-Ramírez, Cynthia Lizeth González-Trevizo

|Oct 16, 2024
Toxicological Evaluation of Kaempferol and Linearolactone as Treatments for Amoebic Liver Abscess Development in Mesocricetus auratus.

Luis Varela-Rodríguez, Fernando Calzada, José Antonio Velázquez-Domínguez

|Oct 23, 2021
Antineoplastic Activity of Rhus trilobata Nutt. (Anacardiaceae) against Ovarian Cancer and Identification of Active Metabolites in This Pathology.

Luis Varela-Rodríguez, Blanca Sánchez-Ramírez, Erika Saenz-Pardo-Reyes

|Nov 24, 2020
Linearolactone and Kaempferol Disrupt the Actin Cytoskeleton in Entamoeba histolytica: Inhibition of Amoebic Liver Abscess Development.

José Antonio Velázquez-Domínguez, Verónica Ivonne Hernández-Ramírez, Fernando Calzada

|Apr 12, 2020
Effect of Gallic acid and Myricetin on ovarian cancer models: a possible alternative antitumoral treatment.

Luis Varela-Rodríguez, Blanca Sánchez-Ramírez, Verónica Ivonne Hernández-Ramírez

Pageof 2